title: Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy.
abstract: Testosterone deficiency (TD) has become a growing concern in the field of men's sexual health, with an increasing number of men presenting for evaluation of this condition. Given the increasing demand for testosterone replacement therapy (TRT), a panel of experts met in August of 2015 to discuss the treatment of men who present for evaluation in the setting of low or normal gonadotropin levels and the associated signs and symptoms of hypogonadism. This constellation of factors can be associated with elements of both primary and secondary hypogonadism. Because this syndrome commonly occurs in men who are middle-aged and older, it was termed adult-onset hypogonadism (AOH). AOH can be defined by the following elements: low levels of testosterone, associated signs and symptoms of hypogonadism, and low or normal gonadotropin levels. Although there are significant benefits of TRT for patients with AOH, candidates also need to understand the potential risks. Patients undergoing TRT will need to be monitored regularly because there are potential complications that can develop with long-term use. This review is aimed at providing a deeper understanding of AOH, discussing the benefits and risks of TRT, and outlining each modality of TRT in use for AOH.
authors.affiliation: Department of Urology, Mayo Clinic, Jacksonville, Florida, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Davidiuk
authors.affiliation: Department of Urology, Mayo Clinic, Jacksonville, Florida, USA.
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Broderick
keywords: Hypogonadism; testosterone deficiency (TD); testosterone replacement